Sarcio, Inc.
- Biotech or pharma, therapeutic R&D
Sarcio has developed a proprietary platform technology that utilizes induced pluripotent stem cells (iPSCs) to grow cartilage tissue, creating a robust source of exosomes that carry regenerative signals to promote healing and repair in osteoarthritic joints.
Exosomes are naturally occurring messengers released by cells that carry proteins, RNA, and signaling molecules. Our proprietary biologics utilize the signalling capabilities of these particles to target damaged tissues, modulate inflammation, and stimulate healing.
Our platform enables a scalable and renewable manufacturing process. This approach enables consistent purity, potency, and therapeutic performance that are critical for both clinical translation and commercial success.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}